Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: To Continue or Stop Preoperatively-the Debate Continues

被引：0
|
作者：
Rajan, Niraja [1 ]
Joshi, Girish P. [2 ]
机构：
[1] Penn State Hlth, Dept Anesthesiol & Perioperat Med, Hershey, PA USA
[2] Univ Texas Southwestern Med Ctr, Dept Anesthesiol & Pain Management, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
来源：
ANESTHESIA AND ANALGESIA | 2024年 / 138卷 / 04期
关键词：
HYPERTENSION; ASSOCIATION; GUIDELINES; MANAGEMENT; RISK;
D O I：
10.1213/ANE.0000000000006825
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：760 / 762
页数：3
相关论文
共 50 条
  • [1] Are angiotensin-converting enzyme inhibitors and angiotensin 2 receptor blockers teratogenic?
    Morton, A. P.
    DIABETIC MEDICINE, 2013, 30 (10) : 1263 - 1264
  • [2] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for the Prevention of Migraines
    Gales, Barry J.
    Bailey, Emilee K.
    Reed, Ashley N.
    Gales, Mark A.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (02) : 360 - 366
  • [3] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension: are they equivalent?
    Kaplan, Norman M.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2015, 9 (08) : 582 - 583
  • [4] Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers in the Treatment of Hypertension
    Benenson, Irina
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2022, 18 (05): : 586 - 587
  • [5] Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide
    Mamdani, Muhammad
    Gomes, Tara
    Greaves, Simon
    Manji, Selina
    Juurlink, David N.
    Tadrous, Mina
    Kennedy, Sidney H.
    Antoniou, Tony
    JAMA NETWORK OPEN, 2019, 2 (10)
  • [6] Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    Koomen, E. R.
    Herings, R. M. C.
    Guchelaar, H. J.
    Nijsten, T.
    CANCER EPIDEMIOLOGY, 2009, 33 (05) : 391 - 395
  • [7] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers
    Shrimpton, A. J.
    Walker, S. L. M.
    Ackland, G. L.
    BJA EDUCATION, 2020, 20 (11) : 362 - 367
  • [8] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review
    Mc Menamin, Una C.
    Murray, Liam J.
    Cantwell, Marie M.
    Hughes, Carmel M.
    CANCER CAUSES & CONTROL, 2012, 23 (02) : 221 - 230
  • [9] The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes
    Padwal, Raj
    Lin, Mu
    Eurich, Dean T.
    JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (03) : 200 - 206
  • [10] Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 201p
    Sanchis-Gomar, Fabian
    Lavie, Carl J.
    Perez-Quilis, Carme
    Henry, Brandon M.
    Lippi, Giuseppe
    MAYO CLINIC PROCEEDINGS, 2020, 95 (06) : 1222 - 1230
12345